This article is more than 5 years old. Information may no longer be current.

KDIGO seeks comments on updating guidelines for treating hepatitis C in chronic kidney disease patients

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Kidney Disease: Improving Global Outcomes is seeking comments on a proposed scope of work to update the guidelines for treating hepatitis C in chronic kidney disease patients.

In the scope of work, KDIGO says they plan to update the following guidelines:

• Detection and Evaluation of HCV in CKD
• Treatment of HCV Infection in CKD
• Preventing HCV Transmission in HD Units
• Management of HCV‐Infected Patients before and after Kidney Transplantation
• Diagnosis and Management of Kidney Diseases Associated with HCV Infection

Download and comment on the scope of work on KDIGO's website.